Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio

Keryx Biopharm Inc (KERX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2012	12-2011	12-2010	12-2009	12-2008
Assets
Current Assets
Cash & Cash Equivalents	14,677	35,252	28,412	16,386	13,143
Marketable Securities	N/A	4,211	100	17,548	2,299
Receivables	N/A	7	0	66	25
Other current assets	430	534	200	1,521	508
TOTAL	$15,107	$40,004	$28,712	$35,521	$15,975

Non-Current Assets
PPE Net	56	67	57	94	182
Investments And Advances	0	0	0	1,914	7,185
Intangibles	3,208	3,208	3,208	3,208	3,208
Other Non-Current Assets	198	209	137	81	84
TOTAL	$3,462	$3,484	$3,402	$5,297	$10,659

Total Assets	$18,569	$43,488	$32,114	$40,818	$26,634

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	7,212	8,870	5,278	5,001	4,613
Accrued Expenses	827	897	669	755	496
TOTAL	$8,039	$9,767	$6,192	$6,032	$6,693

Non-Current Liabilities
Deferred Revenues	N/A	N/A	N/A	156	1,464
Other Non-Current Liabilities	36	2,674	2,674	2,689	4,122
TOTAL	$36	$2,674	$2,674	$2,689	$21,430

Total Liabilities	$8,075	$12,441	$8,866	$8,721	$28,123

Shareholders' Equity
Shares Outstanding, K	81,681	71,023	61,550	56,861	47,832
Common Shares	72	71	62	57	48
Retained earnings	-392,608	-369,887	-341,764	-321,433	-331,918
Other shareholders' equity	-357	-357	-357	-177	-357
TOTAL	$10,494	$31,047	$23,248	$32,097	$-1,489

Total Liabilities And Equity	$18,569	$43,488	$32,114	$40,818	$26,634